Press release
Peptide Synthesis Market Expected to Reach USD 2,175.91 Million by 2034, Growing at a CAGR of 12.4%
The peptide synthesis market is expected to gain market growth during the forecast period of 2025 to 2034. Polaris Market Research analyses the market to account for USD 2,175.91 million by 2034 and is expected to register a CAGR of 12.4% in the above-mentioned forecast period. The market was valued at USD 679.93 million in 2024.Market Definition
A peptide comprises two or more amino acids connected by an amide bond to configure a chain of amino acids coupling agents normally 2-70 amino acids long. Peptides are differentiated by proteins by not needing to be folded for biological tasks. They are synthesized chemically either in solution or in the solid stage. This procedure includes administering and choosing the configuration of an amide bond between N-safeguarded amino acids and an amino acid carrying a free amino group and safeguarded carboxylic acid.
Peptide synthesis is utilized in preventive medicines.
Antibody production services and antibody sequencing services are two important factors of preventive medicines. Subsequently, commercial peptide synthesis firms offer services to research facilities and the vaccine industry. Also, drug detection of the biopharmaceutical applications of peptides capitalizes on a peptide's cellular operations to cure illnesses.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/peptide-synthesis-market/request-for-sample
Competitive Landscape
The market is competitive with the presence of several leading players. Key companies are mentioned below:
• Bachem Holding AG
• Biotage
• Creative Diagnostics
• GenScript
• Lonza
• Merck KGaA
• PolyPeptide Group
• Puresynth Research Chemicals Pvt Ltd.
• Syngene International Limited
• Thermo Fisher Scientific Inc.
Peptide Synthesis Market Report Highlights
• In terms of application, the therapeutics segment led the market in 2024, driven by the growing use of peptide-based drugs for treating diseases such as cancer, metabolic disorders, and autoimmune conditions.
• Based on technology, the hybrid technology segment is anticipated to experience the fastest market growth as it integrates the benefits of both solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).
• North America accounted for the largest share of peptide synthesis market in 2024, supported by significant investments in pharmaceutical and biotechnology research and the presence of major peptide drug manufacturers and research institutions.
• Asia Pacific is expected to see the fastest growth during the forecast period, fueled by increasing biotechnology investments, expanding pharmaceutical manufacturing capabilities, and rising demand for peptide-based therapeutics.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/peptide-synthesis-market/request-for-discount-pricing
Market Growth Drivers and Opportunities
Growing Demand for Peptide-Based Therapeutics: Therapeutic peptides provide precision, productivity, and lesser harm compared to conventional small molecules, making them suitable for curing several illnesses, such as metabolic illnesses, cancer, and infectious illnesses. Thus, peptides have surfaced as an important constituent in contemporary drug advancements thus propelling the peptide synthesis market forward.
Expanding Applications: The augmenting applications of peptide synthesis in diagnostics and imaging assist in market advancement by enhancing illness detection and observation. Peptides are extensively utilized in biomarker recognition, molecular imaging, and earmarked contrast agents because of their superior binding harmony and precision. Their contribution in diagnostic assays, immunoassays and radiolabeled peptides for imaging methodologies has profoundly enhanced the preciseness and productivity of disease detection.
Segmental Analysis
Global Peptide Synthesis Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Peptide Synthesis Market, by Product, 2020-2034 (USD million)
5.3. Equipment
5.3.1. Global Peptide Synthesis Market, by Equipment, by Region, 2020-2034 (USD million)
5.4. Reagents & Consumable
5.4.1. Global Peptide Synthesis Market, by Reagents & Consumable, by Region, 2020-2034 (USD million)
5.5. Services
5.5.1. Global Peptide Synthesis Market, by Drug Discovery Services, by Region, 2020-2034 (USD million)
Global Peptide Synthesis Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Global Peptide Synthesis Market, by Technology, 2020-2034 (USD million)
6.3. Solid Phase Peptide Synthesis (SPPS)
6.3.1. Global Peptide Synthesis Market, by Solid Phase Peptide Synthesis (SPPS), by Region, 2020-2034 (USD million)
6.4. Liquid Phase Peptide Synthesis (LPPS)
6.4.1. Global Peptide Synthesis Market, by Liquid Phase Peptide Synthesis (LPPS), by Region, 2020-2034 (USD million)
6.5. Hybrid Technology
6.5.1. Global Peptide Synthesis Market, by Hybrid Technology, by Region, 2020-2034 (USD million)
Global Peptide Synthesis Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. Global Peptide Synthesis Market, by Therapeutics, 2020-2034 (USD million)
7.3. Therapeutics
7.3.1. Global Peptide Synthesis Market, by Commercial, by Region, 2020-2034 (USD million)
7.4. Diagnosis
7.4.1. Global Peptide Synthesis Market, by Diagnosis, by Region, 2020-2034 (USD million)
7.5. Research
7.5.1. Global Peptide Synthesis Market, by Research, by Region, 2020-2034 (USD million)
Global Peptide Synthesis Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. Global Peptide Synthesis Market, by End Use, 2020-2034 (USD million)
8.3. Academic & Research Institutes
8.3.1. Global Peptide Synthesis Market, by Academic & Research Institutes, by Region, 2020-2034 (USD million)
8.4. Contract Development & Manufacturing Organization/Contract Research Organization
8.4.1. Global Peptide Synthesis Market, by Contract Development & Manufacturing Organization/Contract Research Organization, by Region, 2020-2034 (USD million)
8.5. Academic & Research Institutes
8.5.1. Global Peptide Synthesis Market, by Academic & Research Institutes, by Region, 2020-2034 (USD million)
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/peptide-synthesis-market
Geographical Outlook
Geographically, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the market in 2024 due to robust funding in pharmaceutical and biotechnology research, along with the existence of foremost peptide drug manufacturers and research bodies.
Asia Pacific is witnessing the fastest growth in the peptide synthesis market due to growing funding in biotechnology, augmenting pharmaceutical manufacturing potential, and growing demand for peptide-dependent drugs.
More Trending Latest Reports by Polaris Market Research:
Synoptophore Market
https://www.polarismarketresearch.com/industry-analysis/synoptophore-market
Hereditary Testing Market
https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market
Microcarriers Market
https://www.polarismarketresearch.com/industry-analysis/microcarriers-market
Forensic Imaging Market
https://www.polarismarketresearch.com/industry-analysis/forensic-imaging-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Synthesis Market Expected to Reach USD 2,175.91 Million by 2034, Growing at a CAGR of 12.4% here
News-ID: 4004844 • Views: …
More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…

Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…

Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…

Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…